华润南通医药有限公司

What 华润南通医药有限公司 does

华润南通医药有限公司 (China Resources Nantong Pharmaceutical Co., Ltd.) is a regional pharmaceutical distribution company headquartered in Nantong, Jiangsu Province, China. Founded in 2015, it operates as a wholly-owned subsidiary of China Resources Pharmaceutical Commercial Group Co., Ltd. (华润医药商业集团有限公司), which is part of the state-owned China Resources (华润) conglomerate. The company runs a multi-channel B2B distribution model serving hospitals, community health centers, retail pharmacies, and primary healthcare institutions in the Nantong region, with distinct business segments for hospital direct sales, community health distribution, quick wholesale to retail pharmacies, intra-company allocation within the China Resources network, and traditional Chinese medicine (TCM) materials distribution — for which it serves as the provincial platform within the Jiangsu China Resources network.

The company's core offering is pharmaceutical distribution via a transaction-fee revenue model, supplemented by a portfolio of value-added services. These include a TCM Decoction and Dispensing Center (煎配中心) serving Grade III entrusted hospitals and community clinics, an SPD (Supply Processing Distribution) hospital management project providing drug/material storage, distribution, and ward-level delivery, biological products and vaccine distribution with cold chain capability, and diagnostic reagent and medical consumable channel services. Digital infrastructure consists of internal systems for electronic flow tracking (电子流向查询), electronic quality inspection report queries (电子质检报告), and a downstream customer platform for order management — transactional tools rather than AI-driven systems.

The go-to-market is sales-led and relationship-driven, leveraging the China Resources state-owned enterprise network for institutional access, tender participation, and regulatory standing. The company holds an AAAA-grade logistics enterprise certification (2015), Price Integrity Unit and May 1st Labor Award designations from Chongchuan District Government (2016), and a Law-Abiding and Integrity Demonstration Unit recognition from the Nantong Food and Drug Administration (2016). In September 2025, the company relocated to new headquarters, with capacity expansion signaled by attendance from China Resources Pharmaceutical Commercial Group senior leadership at the ceremony. The customer base spans enterprise hospital accounts, mid-market retail pharmacies, and internal sister-company transfers; supply-side partners include multinational pharmaceutical manufacturers such as GlaxoSmithKline, which conducted strategic evaluation of the company as a priority market in 2016.

Name

华润南通医药有限公司

Legal name

华润南通医药有限公司

Website

https://hrntyy.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

华润南通医药有限公司 is a regional pharmaceutical distributor in Nantong, Jiangsu, operating as a wholly-owned subsidiary of China Resources Pharmaceutical Commercial Group. It serves hospitals, community health centers, and retail pharmacies across multiple distribution channels including TCM provincial platform operations.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG), Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Pharmaceutical & Healthcare Distribution Centers (GDP-compliant) (TLALAEAE)

Keywords

• Pharmaceutical distribution
• Hospital supply
• Chinese herbal medicine
• Medical wholesale
• Pharmaceutical logistics

Headquarters

HQ city

Nantong

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Wholesale pharmaceutical distribution business serving healthcare institutions including hospitals, community health centers, and pharmacies. Operates multiple distribution channels including hospital direct sales, community health networks, and quick wholesale.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

华润南通医药有限公司 is a pharmaceutical distribution company that distributes medicines and medical supplies to hospitals, community health centers, retail pharmacies, and other healthcare institutions across the Nantong region. The company operates multiple business segments including hospital sales, community health distribution, quick wholesale, intra-company allocation, and traditional Chinese medicine materials distribution, serving as the provincial TCM platform within the China Resources network.

Product overview

华润南通医药有限公司 is a pharmaceutical distribution company operating as a subsidiary of China Resources Healthcare Group. The company offers a comprehensive portfolio of pharmaceutical distribution services including Hospital Distribution, Community Health Distribution, Quick Wholesale, Intra-company Distribution, and Chinese Herbal Medicine (as the provincial platform). The business portfolio includes supplementary services such as a TCM Decoction and Dispensing Center serving hospitals and community health centers, SPD (Supply Processing Distribution) hospital management solutions, biological products and vaccine distribution, and diagnostic reagent/medical consumables channels. Digital capabilities include electronic flow tracking and quality inspection report systems for supply chain transparency.

Differentiator

Problem solved

Functional benefit

Products and services

• Hospital Distribution (医院业务)

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• 华润医药集团 (China Resources Pharmaceutical Commercial Group)coreOthersParent company providing management system, strategic direction, and corporate governance framework for the subsidiary operating under the China Resources umbrella.
• 华润苏州礼安医药 (China Resources Suzhou Li'an Pharmaceutical)minorOthersSister company within the China Resources pharmaceutical network, sharing management and operational oversight.
• 华润扬州医药 (China Resources Yangzhou Pharmaceutical)minorOthersSubsidiary under the same parent company, jointly managing fleet vehicle assets and administrative matters.
• 葛兰素史克 (GlaxoSmithKline)coreTechnology or IntegrationGSK conducted on-site research and evaluation in February 2016, considering Huarun Nantong as a key strategic market in the Nantong region. GSK management acknowledged Huarun Nantong's comprehensive market coverage across hospital, community, and retail pharmacy segments, and expressed interest in expanding cooperation.

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Shanghai Pharmaceuticals Holding: Major state-affiliated pharmaceutical distributor and manufacturer with extensive Jiangsu presence. Overlaps in drug distribution to hospitals and retail pharmacies, plus adjacent manufacturing that anchors upstream supply.
• Jointown Pharmaceutical Group: One of China's largest private-sector pharmaceutical distributors with national reach. Competes on hospital distribution contracts, manufacturer rebates, and last-mile service quality across Jiangsu.
• Guangzhou Pharmaceuticals Corporation: Large southern-China-headquartered pharmaceutical distributor that, while regionally rooted, competes for national manufacturer contracts and cross-province distribution tenders. Comparable in scale and operating model to Huarun Nantong's parent group.
• China Grand Pharmaceutical and Healthcare Holdings: Diversified pharmaceutical company with significant distribution operations in eastern China. Overlaps in hospital-facing drug supply and competing for specialty product allocations.
• Sinopharm Group: China's largest pharmaceutical distributor with national network and direct hospital contracts across all provinces including Jiangsu. Competes with Huarun Nantong for manufacturer allocations and hospital supply contracts, but at vastly larger scale and broader product portfolio.

Regional players

• Nanjing Pharmaceutical Co., Ltd. Jiangsu-based regional pharmaceutical distributor operating hospital and retail channels in adjacent geographies. Most comparable in business model and regional positioning, though serves a different city within the same province.

Direct peers

• China Resources Yangzhou Pharmaceutical: Fellow China Resources subsidiary sharing fleet and administrative coordination with Huarun Nantong. Directly comparable regional wholesale distribution profile under the same parent platform.
• China Resources Suzhou Li'an Pharmaceutical: Sister company within the China Resources Pharmaceutical Commercial Group network, operating a parallel pharmaceutical distribution model across Jiangsu. Closest comparable in scope, customer mix, and parent-level operating framework.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/%E5%8D%8E%E6%B6%A6%E5%8D%97%E9%80%9A%E5%8C%BB%E8%8D%AF%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 华润南通医药有限公司